November 7, 2013

Fred's Super Dollar on Thursday reported sales gains for the four weeks ended Nov. 2, reaching $143.4 million on 2% growth.

November 6, 2013

The board of directors of AmerisourceBergen on Tuesday increased the company’s quarterly dividend rate 12% to $0.235 per common share from $0.21 per common share.

November 6, 2013

Once dismissed as belonging to the realm of techno-utopians and anti-government libertarians, bitcoin has lately grown in popularity among investors and retailers. Could it find acceptance among drug stores as well?

November 5, 2013

Endo Health Solutions will acquire Canadian drug maker Paladin Labs for $1.6 billion, mostly in shares of stock, Endo said Tuesday.

November 5, 2013

Hallmark Cards will lay off up to 250 people and drop its party wares line as sales for the category decline, according to published reports.

November 5, 2013

Walgreens on Tuesday posted October sales of $6.4 billion, an increase of 6.1%. Sales in comparable stores increased by 5.8% in October.

November 4, 2013

Carex Health Brands on Monday announced the acquisition of the ThermiPaq Hot & Cold Therapy brand along with other associated assets from the Thermionics Corp..

November 4, 2013

Safeway on Monday announced that it has completed the sale of the net assets of Canada Safeway to Sobeys, a wholly-owned subsidiary of Empire Company.

November 1, 2013

Indian drug maker Dr. Reddy's Labs had sales of $536 million in second quarter 2014 and profits of $110 million, the company said.

November 1, 2013

Teva Pharmaceutical Industries had $5.1 billion in sales and $711 million in profits in third-quarter 2013, the Israeli drug maker said.

October 31, 2013

Cardinal Health had sales of $24.5 billion and profits of $339 million in first quarter 2014, the company said.

October 31, 2013

Mylan experienced a slight dip in sales in its third quarter, due primarily to fluctuating currency values, the generic drug maker said Thursday.

October 31, 2013

Rite Aid's same-store sales increased by 2.1% this month compared with October 2012, the retail pharmacy chain said Thursday, also issuing an estimate of the negative effects of Hurricane Sandy on its sales.

October 30, 2013

A division of inVentiv Health has acquired Catalina Marketing's medication adherence services subsidiary, inVentiv said Thursday.

October 30, 2013

Jim Cramer, host of CNBC's "Mad Money," is still bullish on Rite Aid.

October 30, 2013

The Paws Pet Co. is buying an Irvine, Calif.-based compounding pharmacy as it seeks to transition from a pet company into a pharmaceutical company, Paws said.

October 29, 2013

Actavis had sales of $2.01 billion in third quarter 2013, a 57% increase over the same period last year, the drug maker said Tuesday.

October 29, 2013

Ranbaxy Labs had global sales of $447.6 million in third quarter 2013, compared with $434.6 million in third quarter 2012, the Indian drug maker said Tuesday.

October 29, 2013

A selloff of several store leases and the spinoff of two business segments are on the way for Sears Holdings as the company hopes to improve its third quarter 2013 performance, the retailer said Tuesday.

October 25, 2013

Procter & Gamble may be able to sell its Iams pet food unit to Del Monte Foods Co., according to published reports.

October 24, 2013

GelStat Corp. on Wednesday announced that it has closed the acquisition of CBD Life Sciences.

October 24, 2013

McKesson on Thursday reported $33 billion in revenues for the second quarter ended Sept. 30, up 11% compared to the year-ago period.

October 24, 2013

McKesson on Thursday confirmed its proposed acquisition of Celesio, a leading international wholesale and retail company and provider of logistics and services to the pharmaceutical and healthcare sectors, with an agreement to acquire a majority stake in Celesio for €23 per share (US$31.75 per share) and to launch parallel voluntary public tender offers for the remaining publicly traded shares and outstanding convertible bonds of Celesio.

October 23, 2013

Drug maker Depomed has sold its interests in royalty and milestone payments for several Type 2 diabetes drugs to PDL BioPharma, Depomed said.